I don't have all of the resumes of the BOD at my fingertips, but I think most here recall that those being added to the BOD had great experience in partnerships and sales of companies. This is not a new thought and I would love it if someone else could chime in on this.

CYDY is not built to run trials. If they DEVELOP trials that another company likes, then either partnership or acquisition are most likely and after a point, it becomes cheaper for a company to just acquire CYDY because that company would really be the one doing the heavy lifting.

Again, we all spoke about this a few months back for quite a while. It is not my idea and it is not a new idea.